In This Section

Recruitment Event: Gene Therapy and Hemophilia Research

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

14 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Date:
Jun 16, 2022
-
Event Start Time
8:00 pm to
Event End Time
3:00 pm

The Children’s Hospital of Philadelphia (CHOP) Clinical In Vivo Gene Therapy and NoT Bleeding Programs are seeking to hire Postdoctoral Fellows, Lab Technicians, and Clinical Research Coordinators.

Please join us as Dr. Lindsey George, Dr. Rodney Camire, and Dr. Benjamin Samelson-Jones discuss their groundbreaking work and career opportunities within these rapidly growing programs.

The Clinical In Vivo Gene Therapy group (CIGT) is dedicated to developing and conducting adeno-associated virus gene transfer and molecular therapy trials. With active trials targeting conditions such as hemophilia, muscular dystrophy, gangliosidosis, and rare genetic eye disorders, CIGT seeks to further the development of transformative human therapies and to build upon CHOP’s legacy as a leader in gene therapy research.

The Novel Therapeutics for Bleeding Disorder (NoT Bleeding) Program is an institutionally funded effort to develop new, more effective treatments for patients with bleeding disorders and integrate novel therapies safely into clinical practice. Translational research projects are focused on the use of monoclonal antibodies, gene addition, and gene editing.

This event requires registration in order to add it to your calendar.